Literature DB >> 3108453

Amine oxidases and their endogenous substrates (with special reference to monoamine oxidase and the brain).

P C Waldmeier.   

Abstract

The roles of MAO, BzO, DAO and PAO in the metabolism of endogenous substrates and the functional implications of their action and inhibition is reviewed, the emphasis being on MAO on one hand and on brain on the other. The major issues are the following: There is no discrete subdivision into substrates selective for MAO-A, MAO-B, or mixed ones, but rather a continuum. Tissue differences in substrate specificity are not likely to be due to molecular variability of MAO. For the deamination of DA, 5-HT and PEA at least, the relative participation of either MAO form in a given tissue is primarily determined by the relative abundance of the two forms; only at 10(-5) M and above, substrate concentration begins to matter also. In vivo, compartmentation is of paramount importance: since there seems to be more MAO-A than B inside monoaminergic neurons, DA, 5-HT and NA are predominantly metabolized by MAO-A if metabolism occurs mainly intraneuronally. Conversely, since MAO-B is more abundant extraneuronally, e.g. in glia cells, the relative participation of this form increases if a significant portion of these amines is deaminated outside monoaminergic neurons. In vivo, monoamine deamination is reduced concomitantly with the degree of MAO inhibition, whereas signs of increased transmitter function are only observed if enzyme inhibition is at least 80%. This is likely to be the result of the action of compensatory mechanisms such as feedback inhibition of transmitter release and synthesis. BzO is particularly abundant in vascular tissue, lung and bone. Low levels are found in brain. Endogenous substrates and physiological function are not known. DAO also occurs only in minimal amount in brain, if at all. Its principal substrates are histamine and the polyamines, and the disposal of these amines is probably its main function. Of the PAO's, the type of enzyme found in the rat liver attacks the secondary amino groups and may have a more prominent role in the metabolism of polyamines in the brain than in the periphery. Bovine plasma PAO, which attacks primary amino groups, is only found in the serum of ruminants, but not other species. Its function in the metabolism of polyamines is not known.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108453     DOI: 10.1007/978-3-7091-8901-6_4

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  14 in total

1.  Effect of milacemide on extracellular and tissue concentrations of dopamine and 5-hydroxytryptamine in rat frontal cortex.

Authors:  J Semba; M Doheny; P N Patsalos; G Sarna; G Curzon
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

2.  Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor.

Authors:  Torun Malmlöf; Kristin Feltmann; Åsa Konradsson-Geuken; Frank Schneider; Rudolf-Giesbert Alken; Torgny H Svensson; Björn Schilström
Journal:  J Neural Transm (Vienna)       Date:  2014-06-07       Impact factor: 3.575

3.  Chronic effects of clomipramine and clorgyline on regional levels of brain amines and acid metabolites in rats.

Authors:  D D Mousseau; A J Greenshaw
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

4.  Effects of neonatal bilateral eye enucleation on postnatal development of the monoamines in posterior thalamus of the rat.

Authors:  M L Vizuete; M Santiago; A J Herrera; J L Venero; A Machado; J Cano
Journal:  J Neural Transm Gen Sect       Date:  1991

5.  Involvement of monoaminergic systems in anxiolytic and antidepressive activities of the standardized extract of Cocos nucifera L.

Authors:  Eliane Brito Cortez Lima; Caren Nádia Soares de Sousa; Lucas Nascimento Meneses; Yuri Freitas E Silva Pereira; Natália Castelo Branco Matos; Rayanne Brito de Freitas; Nycole Brito Cortez Lima; Manoel Cláudio Azevedo Patrocínio; Luzia Kalyne Almeida Moreira Leal; Glauce Socorro Barros Viana; Silvânia Maria Mendes Vasconcelos
Journal:  J Nat Med       Date:  2016-10-21       Impact factor: 2.343

6.  Antidepressant, antioxidant and neurotrophic properties of the standardized extract of Cocos nucifera husk fiber in mice.

Authors:  Eliane Brito Cortez Lima; Caren Nádia Soares de Sousa; Germana Silva Vasconcelos; Lucas Nascimento Meneses; Yuri Freitas E Silva Pereira; Naiara Coelho Ximenes; Manuel Alves Santos Júnior; Natália Castelo Branco Matos; Rayanne Brito; Diogo Miron; Luzia Kalyne Almeida Moreira Leal; Danielle Macêdo; Silvânia Maria Mendes Vasconcelos
Journal:  J Nat Med       Date:  2016-02-08       Impact factor: 2.343

7.  Brain microdialysis in rats: a technique to reveal competition in vivo between endogenous dopamine and moclobemide, a RIMA antidepressant.

Authors:  A Colzi; F d'Agostini; A M Cesura; M Da Prada
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat.

Authors:  P T Männistö; P Tuomainen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

Review 9.  Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide.

Authors:  M Mayersohn; T W Guentert
Journal:  Clin Pharmacokinet       Date:  1995-11       Impact factor: 6.447

10.  Kinetic properties of recombinant MAO-A on incorporation into phospholipid nanodisks.

Authors:  F Cruz; D E Edmondson
Journal:  J Neural Transm (Vienna)       Date:  2007-03-29       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.